the board has recommended and declared the dividend of Rs. 0.01/- (1%)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shukra Pharmaceuticals board declared a final dividend of Re. 0.01 per equity share (1% on face value of Re. 1) for FY2025-26, subject to shareholder approval at the AGM. The company reported strong financial performance with standalone revenue from operations growing 74% year-on-year to Rs. 5,670.61 lakhs, while net profit more than doubled to Rs. 2,204.79 lakhs from Rs. 957.51 lakhs in the previous year. Basic EPS improved to Rs. 0.50 from Rs. 0.22. Additionally, the board approved allotment of 17,35,000 equity shares to promoter warrant holders (Dakshesh Shah and Parshva Texchem India Pvt Ltd) upon exercise of warrants at Rs. 25.50 per share, increasing paid-up capital to Rs. 43.96 crores. The company operates in pharmaceutical and MedTech segments.
The dividend of Re. 0.01 per share is minimal and provides negligible income to shareholders. However, the strong profit growth and warrant conversion by promoters indicate confidence in the company's prospects.